Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Recruiting now · Not applicable
Conditions studied: Central Venous Pressure
In brief
Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.
Key facts
- Study ID
- NCT06885073
- Run by
- Compremium AG
- People needed
- 100
- Starts
- 2025-03-10
- Expected to finish
- 2026-03-31
- Last updated by the study team
- 2025-09-18
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provision of signed and dated informed consent form
- Male or female
- Age: birth to 21 years of age
- Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization.
You may not qualify if…
- Weight less than 2.5kg at the time of enrollment.
- Bilateral external jugular veins not accessible due to vascular access or dressing.
- Bilateral skin lesion contraindicating neck Ultrasound
- Active bleeding
- Clinically unstable, per clinical assessment by attending physician and/or surgeon
Where it is running
- Children's National Hospital — Washington D.C., District of Columbia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.